Emergent Product Development Gaithersburg Inc.
Gaithersburg, MD
- UEI
- CNPVCR8DK7M8
- CAGE
- 057Y1
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Emergent Biosolutions Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 300 Professional Dr, Gaithersburg, MD 20879, USA
- Website
- emergentbiosolutions.com
- Founded
- 1998
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $76,775,308 |
| FY2025 | $152,420,122 |
| FY2024 | $245,586,482 |
| FY2023 | $255,687,184 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $76,775,308 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Emergent Biosolutions Canada Inc. | Winnipeg, MB | 325412 Pharmaceutical Preparation Manufacturing |
| Phlow Corp. | Richmond, VA | 325412 Pharmaceutical Preparation Manufacturing |
| On Demand Pharmaceuticals Inc. | Rockville, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Amgen Inc. | Thousand Oaks, CA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Emergent Product Development Gaithersburg Inc. is a for-profit manufacturer registered in SAM.gov since 2002 to receive federal contract awards. The company provides medical countermeasures and pharmaceuticals to federal agencies.
Emergent has received over $1.3 billion in prime federal contracts from HHS and Defense agencies since 2019. This includes a $704 million firm fixed price contract from the HHS Office of the Assistant Secretary for Preparedness and Response to develop filovirus treatments over 10 years. It also includes a $6.9 million Defense Health Agency contract to develop an analgesic ketamine drug and auto injector system. Other contracts are for smallpox vaccines and diluents.
Additionally, Emergent received a $6.3 million National Institutes of Health cooperative agreement in 2019 for a long-acting injectable to treat opioid use disorder. The work is being conducted through August 2022.
Quick answers
Is Emergent Product Development Gaithersburg Inc. registered in SAM.gov?
Yes. Emergent Product Development Gaithersburg Inc.'s SAM.gov registration is active through September 28, 2027.
How much has Emergent Product Development Gaithersburg Inc. received in federal contracts?
Federal contracts obligated $152,420,122 to Emergent Product Development Gaithersburg Inc. in fiscal year 2025 and $730,469,096 in fiscal years 2023 through 2027.
How does Emergent Product Development Gaithersburg Inc. rank among federal contractors?
Emergent Product Development Gaithersburg Inc.'s parent company, Emergent Biosolutions Inc., ranked #1 in NAICS 325414, #2 in PSC AN12 and #4 in NAICS 3254 in FY2025.
What is Emergent Product Development Gaithersburg Inc.'s most recent federal award?
Emergent Product Development Gaithersburg Inc.'s most recent federal contract award is HIV biologics master file support POP: 4/27/26 to 3/31/27, emergent product development gaithersburg, INC (75N98026P00379), from Office of Logisitics and Acquisition Operations (NIH), on April 27, 2026.
On GovTribe
See Emergent Product Development Gaithersburg Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors